ORBIMED ADVISORS LLC 13D/13G Filings for MBX Biosciences, Inc. Common Stock (MBX)

ORBIMED ADVISORS LLC 13D and 13G filings for MBX Biosciences, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-09-23
4:34 pm
Purchase
2024-09-16 13D MBX Biosciences, Inc. Common Stock
MBX
ORBIMED ADVISORS LLC 3,812,215
12.000%
3,812,215increase
(New Position)
Filing